(2006). Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
(2004). Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.
(2006). Adiponectin: a key adipocytokine in metabolic syndrome.
(2004). Association of the human adiponectin gene and insulin resistance.
(2009). Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals.
(1998). Banting lecture 1988. Role of insulin resistance in human disease.
(2004). Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care
(1999). Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study.
(2010). Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis
(2002). Disruption of adiponectin causes insulin resistance and neointimal formation.
(2005). Elderly Nutrition and Health Survey in Taiwan (1999-2000): research design, methodology and content.
(2009). Fibrinogen independently predicts the development of ischemic stroke in a Taiwanese population: CVDFACTS study.
(2006). Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians.
(2002). Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.
(2005). Genetics of human hypertension.
(2004). Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25.
(2005). Genomewide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis.
(2005). Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.
Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese americans.
(2006). Human genetics of adiponectin in the metabolic syndrome.
(2005). Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
(2006). Left ventricular mass and +276 G/G single nucleotide polymorphism of the adiponectin gene in uncomplicated obesity.
(2000). Linkage analysis with candidate genes: the Taiwan young-onset hypertension genetic study.
(1986). Longitudinal data analysis for discrete and continuous outcomes.
(2005). Low adiponectin level in young normotensive men with a family history of essential hypertension.
(2007). Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis.
(2004). Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13.
(1999). Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity.
(2004). Prognostic value of the metabolic syndrome in essential hypertension.
(2004). Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53(Suppl 1):
(2005). The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men.